Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US12071420B2 · kind B2 · utility
0Cited by
10References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 17, 2020 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Nov 27, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a compound of formula (I) wherein A1, A2, X and R1-R3 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.